Overview


According to FutureWise analysis, the market for Per-Encounter Medical is expected to grow with a CAGR of 16% over the forecast period 2023-2031, and reach a market value of US$ 380.30 billion by 2031.

Per-Encounter Medical refers to a type of healthcare service or billing model where a healthcare provider charges a fixed fee for each individual visit or encounter with a patient. This means that regardless of the complexity or duration of the visit, the patient is billed a predetermined amount for that particular visit. This model contrasts other billing methods, such as fee-for-service or capitation. In fee-for-service, healthcare providers bill for each individual service or procedure performed. In capitation, providers receive a fixed payment per patient for a specific period, regardless of the number of visits or services provided. Per-encounter medical billing can be common in settings such as critical care centers, walk-in clinics, or specific procedures that are relatively standardized in terms of time and resources required.

There are different types of products for a per-encounter medical and their application, including consumables; these are products that are meant to be used up or depleted after a single use or within a short period. This could include bandages, syringes, gloves, or other supplies used during a single medical encounter. Also, medical devices are instruments, apparatuses, machines, or implants used to diagnose, treat, monitor, or prevent disease or other conditions. Examples include blood pressure monitors, thermometers, pacemakers, and scanning machines like MRI or X-ray machines. Further, medical software refers to applications or programs designed to assist in managing and delivering healthcare services. This could include electronic health record (EHR) systems, medical imaging software, telemedicine platforms, and other specialized medical software applications.

FutureWise Market Research has published a report that provides an insightful analysis per-encounter medical market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts per-encounter medical market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Abbott
  • BD
  • Cardinal Health
  • Johnson & Johnson
  • Medtronic
  • 3M
  • Steris
  • Teleflex

(Note: The list of the major players will be updated with the latest market scenario and trends)

The escalating prevalence of chronic conditions, such as diabetes, hypertension, and heart disease, signifies a fundamental shift in the per encounter medical market. Patients with chronic conditions require ongoing, specialized care and management. This rise in demand for regular medical consultations not only underscores the necessity for accessible and convenient healthcare solutions but also serves as a critical driver for the per-encounter medical market. By offering specialized, on-demand care for these conditions, providers can address the growing need for frequent medical attention, aligning with the evolving healthcare landscape. Additionally, the rapid adoption of telehealth and remote care technologies represents a significant advancement in modern healthcare delivery. These innovations transcend geographical barriers, allowing patients to access medical services from the convenience of their own homes. This increased convenience is a significant driver for the per-encounter medical market, as it aligns with the model's emphasis on efficient, individualized care. By leveraging these technologies, providers may offer timely consultations and treatments, enhancing patient satisfaction and optimizing resource utilization. This trend addresses the evolving preferences of healthcare consumers and positions per-encounter services at the forefront of accessible and patient-centric care. However, in certain healthcare systems, the reimbursement system for per-encounter services might be less favorable compared to alternative models like fee-for-service or bundled payments. This financial disparity may pose a significant challenge for providers, potentially limiting the profitability and sustainability of per-encounter medical services. Also, navigating the intricate landscape of healthcare regulations and compliance standards may be a major barrier for new entrants. The costs associated with ensuring adherence to these standards, both in terms of time and resources, can be substantial, deterring potential providers from entering the per-encounter medical market. Therefore, restraining the market expansion.

By Product Type 

  • Consumables
  • Devices
  • Software
  • Services
  • Others

By Application

  • Cardiology
  • Orthopedics
  • Obstetrics/Gynecology
  • Ophthalmology
  • Gastroenterology
  • Others

By End-User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

By Distribution Channel

  • Direct Tender
  • Retail Sales
  • Online Sale

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to factors such as the increasing incidence of chronic diseases, expanding elderly population, routine medical check-ups and procedures, advanced healthcare infrastructure, technological advancements in medical devices, and favorable reimbursement policies in the region, which is anticipated to fuel the growth of the per-encounter medical market during the forecast period. In addition, the increasing adoption of home healthcare services, rising focus on sustainability among healthcare providers, merger and acquisition, advanced materials like engineered composites, and product launches are also boosting the market expansion in the area. For instance, in June 2021, Owens & Minor acquired Apria, a provider of integrated home healthcare products and services, for around $1.45 billion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Per-Encounter Medical Market By Product Type, By Application, By End-User, By Distribution Channel, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2. Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Per-Encounter Medical Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Per-Encounter Medical Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Per-Encounter Medical Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Per-Encounter Medical Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Consumables
      2. Devices
      3. Software
      4. Services
      5. Others
  • 8.  Per-Encounter Medical Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Cardiology
      2. Orthopedics
      3. Obstetrics/Gynecology
      4. Ophthalmology
      5. Gastroenterology
      6. Others
  • 9.  Per-Encounter Medical Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Diagnostic Centers
      4. Others
  • 10.  Per-Encounter Medical Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Direct Tender
      2. Retail Sales
      3. Online Sale
  • 11.  North America Per-Encounter Medical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.  Latin America Per-Encounter Medical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.  Europe Per-Encounter Medical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.  Asia Pacific Per-Encounter Medical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031  

  • 15.  Middle East and Africa Per-Encounter Medical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. BD
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Cardinal Health
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Johnson & Johnson
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Medtronic
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. 3M
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Steris
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Teleflex
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients